الهدف: دراسة حدوث ارتفاع I.O.P بعد حقن تريامسينولون تحت التينون
الطرق : تمت الدراسة على 40 مريض 50 عيناً تلقوا 40 مغ تريامسينولون تحت التينون لعلاج أمراض مختلفة تمت مراقبة الضغط داخل المقلة و تحديد العيون التي ارتفع فيها الضغط ≥ 5 ملمز و ذروة I.O.P
و العلاقة بين I.O.P و العمر و الجنس و نوع المرض وعدد الحقن
النتائج : I.O.P ≥ 5 ملمز وجد في 25 عيناً أي 50% من العيون المدروسة
بدأ ارتفاع I.O.P بشكل هام بعد شهر من الحقن( 20% ) وصل إلى الذروة بعد 3 أشهر
( 80 % ) و عاد إلى المستوى الأساسي قبل الحقن بعد 10 أشهر
يزداد I.O.P عند الشباب 80 % بالأعمار بين 40– 50 سنة وعند الإناث >الذكور ( 59,09% و 42,8%) على التوالي, وبالحقنة الوحيدة أقل من الحقن المتعددة ( 47,3% و 60%)على التوالي
لا يوجد علاقة هامة بين نوع المرض المعالج و حقن التريامسينولون تحت التينون
الاستنتاج: تعدد الحقن و الأعمار الشابة و خصوصاً بين النساء يزيد نسبة حدوث ارتفاع I.O.P بعد حقن التريامسينولون تحت التينون.
Purpose : to determine the incidence of eyes that have an increase in the intraocular pressure( I.O.P ) after subtenon injection of triamcinolone acetonide . Methods: 40 patient 50 eyes treated with 40 mg subtenon injection of TA for different diseases. The incidence of an I.O.P elevation ≥ 5mmhg was determine, the peak of I.O.P, the relation between I.O.P elevation and the age, gender, the kind of disease and the number of we injections of ta Results : an elevation I.O.P≥ 5mmhg was found in 25 eyes ( 50%) . The I.O.P began to increase significantly from 1 month (20%) The peak of I.O.P after 3 months (80%) and returned to the baseline I.O.P in 10 months . the elevation I.O.P≥ 5 mmhg was significantly related with younger age (80%) between 40-50 years the elevation I.O.P is between females' more in cedence than males (59,59%) females and (42,8%) males, and is less incidence aftere single injection (42.8%) less than multi injection (60%) multiple No significant relation is round between the disease and the incidence of increased I.O.P . Conclusion : repeated injections of TA and injection of younger patients especially women increase the incidence of an I.O.P elevation .
References used
yumikoyamamoto, md, tsutomukomatsu, mdyujikoura, mdkojinishino, md, phdatsukifukushimamd, phd, hisayukiueno , md. Intraocular pressure elevation after ibtravitreal or posterior sub tenon triamcinolone acetonide injection Canadian journal of ophthalmology volume 43,issue 1 February 2008 ,p 42-47, sciencedirect
sophiebakri md peter k Kaiser ,md, posterior subtenon triamcinolone acetonide for refractory diabetic macular edema American journal of ophthalmology volume 139,issue 2 february 2005,p 290-294
Ryosuke kawamura.makoto. hajimeshinoda. keishinoda . yujiitoh. susumuishida. Incidence of increased intraocular pressure after subtenon injection of triamcinolone acetonide , Americen Journal of gohthalmalogy,juni2011(3);299-304
The aim of this clinical study was to investigate the intraocular pressure (IOP) reduction after selective laser trabeculoplasty (SLT) in patients with primary open-angle glaucoma (POAG). The research has been done in Alassad Hospital, Tishreen unive
In this study 500 obese pregnant women and 250 non-obese pregnant women
(Group of Control) were followed up to prove the role of obesity as a high risk
factor on the incidence of (P.I.H.). We found that:
1. There is a considerable increase in the
The study aims to investigate the efficacy of subcutaneous Betamethasone phosphate sodium injection in the treatment of chalazion. The research was carried out in Al-Assad Hospital, Tishreen University, Lattakia, in the period from January 2009 to De
The study was performed in 64 children aged 6 months to 5 years had
ventricuLar septal defect. Systolic pressure in the right ventricle and
Pulmonary Hypertension were determined by two ways.
1- From arteriovenous shunt via ventricular septal defe
Objective: Keloid pose aesthetic and functional problems, in addition to being associated with disturbing clinical symptoms such as itching and pain, and current methods of treatment are limited in effectiveness. Clinical studies indicate that botuli